Patient identification and clinical audit
Identifying patients and initiating diagnosis of suspected cases to optimise care.
Identifying patients, optimising care
At Ashfield, we have a long, well-respected record of success in patient identification and clinical audit services across a range of therapy areas and patient types
Identifying patients and initiating diagnosis of suspected cases
Early detection of genetic disorders is key for patient survival. However, DNA analytics and sophisticated diagnosis is only possible in centres for rare diseases or through a specialist.
Often, many primary care doctors don’t link symptoms to rare diseases, so we can support them through multichannel campaigns that raises awareness, educating doctors on symptoms and initiating referrals to experts in diagnosis and treatment.
Ultimately, our aim is to save more patients lives and help them get the medicines and support they need.
Clinical audits to improve clinical pathways and optimise patient care
Our non-promotional clinical audit service is delivered in primary and secondary care settings. We can:
- Identify patients sub-optimally treated according to local or national guidelines
- Review and improve clinical paths and outcomes, for example running a nurse-led clinic and making recommendations to optimise patient care
- Generate data that can be widely shared through scientific publications
Our clinical audit service is delivered through highly qualified nurse advisors. It is conducted with the highest compliance and adherence to all relevant local and international codes and policies.
Recent Case Studies
Ashfield takes over our client’s medical information service after a surge in demand caused customer service levels to drop
Ashfield delivers a PSP for a rare disease, with hands-on patient care and high-quality support materials
Speak to us about how we can provide tailor made solutions for you.
Ashfield offers a wide range of world-class, market leading services that include medical sales teams, telesales, nurse educators, patient support programmes, medical communications, medical information, meetings and events, market research, pharmacovigilance and training.